DISCUSSION: The majority of chylothoraces are secondary to trauma (50% of cases). This case, however was attributed to lymphoma, which is the cause of 11% of cases. Other causes include congenital diseases or systemic diseases (systemic lupus erythematosus, Behçet disease). They generally present as unilateral effusions, but 20% may be bilateral. Surgical treatment had been the preferred modality; however noninvasive procedures have become more commonplace with reduced morbidity and mortality. Percutaneous treatment of a chylothorax was developed as a minimally invasive alternative to surgical treatment. The treatment consists of transabdominal catheterization of the cysterna chyli with embolization of the thoracic duct proximal to the chyle leak. Embolization coils are used to pack the lumen of the thoracic duct and impede flow. In addition to lowering morbidity and mortality, lymphangiograms lend the ability to identify the chyle leak and variations in thoracic duct anatomy which potentially improve the outcome.